The French biochemist Emmanuelle Charpentier and the American molecular biologist Jennifer Doudna have won the Princess of Asturias Foundation's annual award.
Charpentier and Doudna, based at the Laboratory for Molecular Infection Medicine Sweden in Umeå and the University of California, Berkeley, respectively, were awarded the prize for their joint work on genome-editing technology that allows researchers to rewrite defective genes and correct them.
The jury for the annual award said their work had initiated “a revolution in biotechnology and holds a great promise for gene therapy and in the treatment of diseases such as cancer and cystic fibrosis, among others”.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.